Related Experiment Video
Updated: Feb 24, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
A database of breast oncogenic specific siRNAs
Atul Tyagi1, Manoj Semwal2, Ashok Sharma3
1Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Near Kukrail Picnic Spot, Lucknow, 226 015, Uttar Pradesh, India. ks26atul@gmail.com.
Researchers created the Breast Oncogenic Specific siRNAs (BOSS) database, a valuable resource for identifying specific small interfering RNAs (siRNAs) to target genes in breast cancer research and drug development.
Area of Science:
- Biochemistry
- Bioinformatics
- Molecular Biology
Background:
- Breast cancer poses a significant global health challenge, necessitating targeted gene therapies.
- RNA interference (RNAi) offers a promising avenue for gene silencing in cancer treatment.
- Identifying specific oncogene targets is crucial for developing effective breast cancer drugs.
Purpose of the Study:
- To develop a comprehensive database of experimentally validated breast oncogenic siRNAs.
- To provide a centralized resource for researchers studying siRNA-mediated gene repression in breast cancer.
- To facilitate the discovery of novel therapeutic strategies for breast cancer.
Main Methods:
- Compilation of siRNA data from scientific literature and patents.
- Development of the Breast Oncogenic Specific siRNAs (BOSS) database.
- Integration of bioinformatics tools, including siRNAMAP and BOSS BLAST.
Main Results:
- The BOSS database contains 865 entries of validated breast oncogenic siRNAs.
- Each entry includes detailed information such as siRNA sequence, target gene, cell type, and inhibition efficacy.
- Linked tools aid in selecting optimal siRNAs and locating them within oncogenes.
Conclusions:
- The BOSS database serves as a vital resource for breast cancer research and therapeutic development.
- It supports the identification and design of specific siRNAs for targeting oncogenes.
- This resource can accelerate the advancement of RNAi-based breast cancer treatments.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
lncRNA - Long Non-coding RNAs
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...